Perioperative management of patients receiving non-vitamin K antagonist oral anticoagulants: up-to-date recommendations
Indications of non-vitamin K antagonist oral anticoagulants (NOACs), consisting of two types: direct thrombin inhibitor (dabigatran) and direct factor Xa inhibitor (rivaroxaban, apixaban, and edoxaban), have expanded over the last few years. Accordingly, increasing number of patients presenting for...
Main Authors: | Kwang-Sub Kim, Jong Wook Song, Sarah Soh, Young-Lan Kwak, Jae-Kwang Shim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Anesthesiologists
2020-04-01
|
Series: | Anesthesia and Pain Medicine |
Subjects: | |
Online Access: | http://www.anesth-pain-med.org/upload/pdf/apm-2020-15-2-133.pdf |
Similar Items
-
Characteristics of Novel Anticoagulants versus Vitamin K Antagonists in the Ventricular Mural Thrombus
by: Qing Yang, et al.
Published: (2023-03-01) -
Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care
by: Gianfranco De Girolamo, et al.
Published: (2022-04-01) -
Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
by: Heng Cai, et al.
Published: (2020-01-01) -
Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists
by: Martin Müller, et al.
Published: (2019-04-01) -
Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation – real-life data from a survey in Eastern Switzerland
by: Micha T. Maeder, et al.
Published: (2017-10-01)